Penumbra, Inc Net Income (Loss) Attributable to Noncontrolling Interest
Penumbra, Inc (PEN) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2024-02-22
- Penumbra, Inc net income (loss) attributable to noncontrolling interest for the quarter ending 2022-12-31 was $0.00.
- Penumbra, Inc net income (loss) attributable to noncontrolling interest for the quarter ending 2022-09-30 was $0.00.
- Penumbra, Inc net income (loss) attributable to noncontrolling interest for the quarter ending 2022-06-30 was $0.00.
- Penumbra, Inc net income (loss) attributable to noncontrolling interest for the quarter ending 2022-03-31 was $0.00.
- Penumbra, Inc net income (loss) attributable to noncontrolling interest for fiscal 2023 was $0.00.
- Penumbra, Inc net income (loss) attributable to noncontrolling interest for fiscal 2022 was $0.00.
- Penumbra, Inc net income (loss) attributable to noncontrolling interest for fiscal 2021 was -$2.66M.
- Penumbra, Inc net income (loss) attributable to noncontrolling interest for fiscal 2020 was -$3.56M.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-22 | |||
| 2022-12-31 | $0.00 10-K · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | $0.00 10-K · filed 2024-02-22 |
| 2022-09-30 | $0.00 10-K · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 10-Q · filed 2022-11-03 | $0.00 derived: sum of 4 quarters · filed 2023-02-23 |
| 2022-06-30 | $0.00 10-K · filed 2023-02-23 | $0.00 10-Q · filed 2022-08-05 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | -$819.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2022-03-31 | $0.00 10-K · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | -$819.00K derived: sum of 3 quarters · filed 2023-02-23 | -$1.75M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-23 | -$819.00K derived: sum of 2 quarters · filed 2023-02-23 | -$1.75M derived: sum of 3 quarters · filed 2023-02-23 | -$2.66M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$819.00K 10-K · filed 2023-02-23 | -$1.75M derived: sum of 2 quarters · filed 2023-02-23 | -$2.66M 10-Q · filed 2022-11-03 | -$3.68M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$932.00K 10-K · filed 2023-02-23 | -$1.84M 10-Q · filed 2022-08-05 | -$2.86M derived: sum of 3 quarters · filed 2023-02-23 | -$3.92M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$910.00K 10-K · filed 2023-02-23 | -$1.93M derived: sum of 2 quarters · filed 2023-02-23 | -$2.99M derived: sum of 3 quarters · filed 2023-02-23 | -$3.93M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | -$1.02M 10-K · filed 2022-02-22 | -$2.08M derived: sum of 2 quarters · filed 2022-02-22 | -$3.02M derived: sum of 3 quarters · filed 2022-02-22 | -$3.56M 10-K · filed 2023-02-23 |
| 2020-09-30 | -$1.06M 10-K · filed 2022-02-22 | -$2.00M derived: sum of 2 quarters · filed 2022-02-22 | -$2.54M 10-Q · filed 2021-11-03 | -$2.93M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | -$941.00K 10-K · filed 2022-02-22 | -$1.48M 10-Q · filed 2021-08-09 | -$1.87M derived: sum of 3 quarters · filed 2022-02-22 | -$2.35M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | -$537.00K 10-K · filed 2022-02-22 | -$925.00K derived: sum of 2 quarters · filed 2022-02-22 | -$1.41M derived: sum of 3 quarters · filed 2022-02-22 | -$1.75M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | -$388.00K 10-K · filed 2021-02-23 | -$871.00K derived: sum of 2 quarters · filed 2021-02-23 | -$1.21M derived: sum of 3 quarters · filed 2021-02-23 | -$1.45M 10-K · filed 2022-02-22 |
| 2019-09-30 | -$483.00K 10-K · filed 2021-02-23 | -$822.00K derived: sum of 2 quarters · filed 2021-02-23 | -$1.07M 10-Q · filed 2020-11-02 | -$1.26M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | -$339.00K 10-K · filed 2021-02-23 | -$583.00K 10-Q · filed 2020-08-03 | -$778.00K derived: sum of 3 quarters · filed 2021-02-23 | -$4.27M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | -$244.00K 10-K · filed 2021-02-23 | -$439.00K derived: sum of 2 quarters · filed 2021-02-23 | -$3.94M derived: sum of 3 quarters · filed 2021-02-23 | -$3.94M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | -$195.00K 10-K · filed 2020-02-26 | -$3.69M derived: sum of 2 quarters · filed 2020-02-26 | -$3.69M derived: sum of 3 quarters · filed 2020-02-26 | -$3.69M 10-K · filed 2021-02-23 |
| 2018-09-30 | -$3.50M 10-K · filed 2020-02-26 | -$3.50M derived: sum of 2 quarters · filed 2020-02-26 | -$3.50M 10-Q · filed 2019-11-07 | -$3.50M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $0.00 10-K · filed 2020-02-26 | $0.00 10-Q · filed 2019-08-06 | $0.00 derived: sum of 3 quarters · filed 2020-02-26 | $0.00 derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $0.00 10-K · filed 2020-02-26 | $0.00 derived: sum of 2 quarters · filed 2020-02-26 | $0.00 derived: sum of 3 quarters · filed 2020-02-26 | $0.00 derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-26 | $0.00 derived: sum of 2 quarters · filed 2019-02-26 | $0.00 derived: sum of 3 quarters · filed 2019-02-26 | $0.00 10-K · filed 2020-02-26 |
| 2017-09-30 | $0.00 10-K · filed 2019-02-26 | $0.00 derived: sum of 2 quarters · filed 2019-02-26 | $0.00 10-Q · filed 2018-11-05 | |
| 2017-06-30 | $0.00 10-K · filed 2019-02-26 | $0.00 derived: sum of 2 quarters · filed 2019-02-26 | ||
| 2017-03-31 | $0.00 10-K · filed 2019-02-26 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |